ClinicalTrials.gg
Sign In

Blepharoptosis clinical trials

The registry lists 75 studies for Blepharoptosis across more than 10 countries. 14 are recruiting or about to start. 62 of them are mainly about Blepharoptosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Blepharoptosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
39
Status unknown
14
Recruiting
11
Terminated
4
Not yet recruiting
3
Withdrawn
3

Phase

Phase 4
12
Phase 3
8
Phase 2
7
Phase 1
2
Early Phase 1
2

Where

United States
30
Israel
10
Egypt
5
China
4
Spain
4
Canada
4

Who runs them

Sheba Medical Center (5) · University of Miami (4) · RVL Pharmaceuticals, Inc. (4) · Massachusetts Eye and Ear Infirmary (3) · Meir Medical Center (3) · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (2) · University of California, San Francisco (2) · Santen Pharmaceutical Co., Ltd. (2)

What is being tested here

Drugs under test in Blepharoptosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Brimonidine204
Oxymetazoline113
RVL-1201023
Botulinum toxin type A002
Bupivacaine012
Lidocaine001
Fibrin Tissue Adhesive011

Drug classes tested here Local anesthetics 3

Coming up

1phase 3 study under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 11 Blepharoptosis studies recruiting now, 7 (64%) set no upper age limit and 3 (27%) stop at 75 or younger. 3 (27%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (27%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
103 (27%)3 (27%)
1810 (91%)10 (91%)
309 (82%)9 (82%)
4010 (91%)10 (91%)
5010 (91%)10 (91%)
659 (82%)9 (82%)
759 (82%)9 (82%)
858 (73%)8 (73%)

Across all 75 studies, recruiting or not: 21% stop at 75 or younger and 12% at 65; 29% take children; 3% are for women only and 0% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Blepharoptosis studies take

Of 24 interventional studies with no phase under Blepharoptosis, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo13–57 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 75. Browse all 75 → or search them.